Pediatric rheumatology

Association of NXP2 autoantibodies with a more severe clinical phenotype of juvenile dermatomyositis

Clin Exp RheumatolPublished Cohort study

Authors' conclusion

The NXP2+ JDM patients experience more severe muscle damage, systemic complications, and higher relapse risks.

Study context

Population
Patients with juvenile dermatomyositis (JDM) positive for anti-NXP2, anti-MDA5 or anti-TIF1γ, and NXP2+ adult DM patients
Participants
18 / 12 / 12 / 20
Exposure
NXP2+ JDM vs MDA5+ JDM, TIF1γ+ JDM and NXP2+ adult DM
  • NXP2+ JDMn = 18
  • MDA5+ JDMn = 12
  • TIF1γ+ JDMn = 12
  • NXP2+ adult DMn = 20
Outcome
Serum creatine kinase levels
Methodological detailscomparative, 3-year follow-up, repeated measures analysis, Kaplan-Meier and Cox regression
  • Comparative
  • 3-year follow-up
  • Repeated measures analysis
  • Kaplan-Meier and Cox regression

Main finding

As reported in the abstract

NXP2+ JDM

3792

MDA5+ JDM

180

NXP2+ adult DM

437.5

TIF1γ+ JDM

189

NXP2+ JDM vs MDA5+ JDM: P < 0.001 · NXP2+ JDM vs NXP2+ adult DM: P = 0.003 · NXP2+ JDM vs TIF1γ+ JDM: P < 0.001

Observational data: associations, not effects.

Further findings

OutcomeNXP2+ JDMMDA5+ JDMTIF1γ+ JDMP value
CMAS scoresNXP2+ JDM vs MDA5+ JDM31.3343.2542.67P < 0.001
CMAS scoresNXP2+ JDM vs TIF1γ+ JDMP = 0.004

Clinical complications

NXP2+ JDM presented with a high frequency of macrophage activation syndrome (MAS), myocardial damage, dysphagia and calcinosis

Longitudinal muscle damage (repeated measures) · throughout the disease course

NXP2+ JDM had more severe muscle damage than MDA5+ JDM and TIF1γ+ JDM
Significant Group × Time interaction effects on creatine kinase (CK) in JDM

Relapse risk · 3-year follow-up

Higher relapse risk in NXP2+ JDM vs MDA5+ JDM, TIF1γ+ JDM and NXP2+ adult DM

Original publication

Association of NXP2 autoantibodies with a more severe clinical phenotype of juvenile dermatomyositis. Clin Exp Rheumatol. Published 9 April 2025. doi:10.55563/clinexprheumatol/820f4x

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.